Lung cancer is a major public health problem due to its high incidence and mortality rate. The altered metabolism in lung cancer is key for the diagnosis and has implications on both, the prognosis and the response to treatments. Although Cancer-associated fibroblasts (CAFs) are one of the major components of the tumor microenvironment, little is known about their role in lung cancer metabolism.
, tumor progression [6] , and treatment response [7] . Therefore, additional studies on cancer metabolism are needed taking into account this complexity, since most studies have focused exclusively on analysis of isolated tumor cell lines. It is likely that the discrepancy between cancer basic knowledge and its clinical application is due to underestimation of the microenvironment component of tumors. One of the most important components of the tumor microenvironment are the cancer associated fibroblasts (CAFs) [8] , identified by the expression of proteins such as α-smooth muscle actin (α-SMA) and fibroblast activation protein (FAP) [9] . The role of CAFs at metabolic level has been recently described as the Reverse Warburg effect. According to this model, tumor cells within the microenvironment would activate the fibroblasts present by different factors and would control them, taking advantage of their metabolism. Although this phenomenon is still not completely understood, it seems to implicate a decrease on mitochondrial function in CAFs with the ensuing increase on glycolysis. This metabolic shift would lead to a release of highly energetic metabolic substrates to the microenvironment that would be used by the tumor cells through an increased OXPHOS function [10] [11] [12] [13] .
We have focused on lung cancer because it is a major public health problem. Lung cancer is the most common cancer worldwide in terms of incidence and it is also the leading cause of cancer-related death in the world despite new targeted therapies based on their mutational profile have been incorporated [14] [15] [16] . Approximately one-third of patients with non-small cell lung cancer (NSCLC) are diagnosed with locally advanced (stage III) disease. These patients experience poor overall survival due to the presence of metastatic diseases that are not adequately detected. Therefore, many patients are subjected to aggressive localized treatments, such as surgery or radiotherapy, when they already present advanced distant disease [17] .
Usually lung tumors have a variable component of mesenchymalparenchyma composed mainly of fibroblasts and collagen fibers [18] . Importantly, in spite of the clinical relevance of lung cancer (in which FDG-PET is a key diagnostic tool [19] and the fibroblasts are an important component of tumors [20] ) the role of the microenvironment in metabolic reprogramming has not been studied.
Our results on stage IIIA NSCLC patients show a positive correlation between the grade of fibrosis and the glycolysis phenotype of the tumor. In vitro studies confirm that, a metabolic reprogramming involving ROS and TGF-β signaling occurs in lung cancer cells and fibroblasts independently of α-SMA induction and suggest that specific attributes among tumor cells and fibroblasts may modify or hamper this phenomenon.
Materials and methods

Patients
A cohort of 12 stage IIIA adenocarcinoma patients was studied. All studies were carried out using the Formalin-Fixed Paraffin Embedded tissue (FFPET) from diagnostic biopsies. All the experiments carried out in this study complied with current Spanish and European Union laws and the principles outlined in the Declaration of Helsinki. The study and experimental protocols were approved by the Hospital Universitario Puerta de Hierro Ethics Committee and written informed consent was obtained from all the patients recruited.
Fibrosis grade
The fibrosis grade was evaluated in the hematoxylin-eosin diagnostic slides at x50 magnification. A low (< 1/3 desmoplastic stroma) or high (> 1/3 desmoplastic stroma) score was assigned to each sample by three independent anatomical pathology technicians. Vimentin and cytokeratin immunostaining of tumor biopsies using specific antibodies were carried out to confirm the correct identification of tumor cells and fibroblasts on the hematoxylin-eosin samples.
RT-qPCR expression analysis
The RNA extraction from FFPET biopsies was performed using the "High Pure FFPET RNA isolation Kit" (Roche). The RNA from cells was extracted using the "RNeasy mini Kit with DNAse" (Qiagen) and the cDNA was synthetized using the "NZY First-Strand cDNA Synthesis Kit" (NZYtech).
PGC-1α, GAPDH, MT-CO1, LDHA, α-SMA, MCT4 and TGF-β mRNA expression was measured by qRT-PCR using the Taqman® gene expression assays Hs01016719_m1, Hs02758991_g1, Hs02596864_g1, Hs01378790_g1, Hs00426835_g1, Hs00358829_m1 and Hs00998133_m1 respectively. TBP (Hs00427621_m1) was used as endogenous control [21] .
In silico analysis of TCGA patients
73 stage IIIA lung adenocarcinoma patients were analyzed using R2: Genomics Analysis and Visualization Platform (http://r2.amc.nl, dataset id "Tumor lung adenocarcinoma -TCGA -515 -rsem-tcgars").
Cell lines
A549 and H1299 were obtained from the ATCC, Control Fibroblasts 1, 2 and 3 (CF1, CF2, CF3) were primary cultures derived from healthy donors and the Affected Fibroblast (AF) is the commonly used BJ h-tert immortalized fibroblast. The word "affected" indicates that this fibroblast has a reduced OXPHOS function of unknown origin, as described in results section.
The H1229 cell line was transfected with the plasmid pKatushka2S (K2S from now) [22] using lipofectamine 2000 reagents (Thermo Fisher Scientific) following manufacturer instructions. The efficiency was evaluated by flow cytometry and 48 h after transfection the cells were selected for one month in DMEM containing G418 0,5 mg/mL. Several clones were isolated by limit dilution and evaluated for their growing capabilities in glucose/galactose, fluorescence intensity, and transfection stability (data not shown). The K2S positive clone, with more similar properties to the parental H1299 cell line, named H1299 K2S, was used to carry out all the following experiments.
All cells were cultured routinely in DMEM, with 10% Fetal Bovine Serum (FBS) and Penicillin Streptomycin (Gibco).
Galactose and glucose growth rates
Cell growth was assayed as described previously [23] . Briefly, cell growth was assayed after growing the cells for 4 days in DMEM containing either 4.5 g/L glucose or 0.9 g/L galactose as carbon source. The cells were harvested and counted every 24 h and the growth rates were calculated using Doubling Time Software v3.1.0 (http://www.doublingtime.com). Mean was calculated from at least three different experiments.
The experiments involving fibroblast cells were seeded at 1:3 ratio (tumor cell line: fibroblast). The day of the analysis, cell lines proportions were near 1:1 due to their diverse growth rates. For the effect between different tumor cell lines (A549 and H1299), cells were seeded accordingly to their growth rate to reach approximately a final ratio of 1:1.
To study the involvement of the basal fibroblast OXPHOS function in this process, fibroblasts were treated with 50 µg/mL of EtBr prior the experiments. After four days of drug exposure, the EtBr was removed and the fibroblasts were co-cultivated and analyzed as described above.
Flow cytometry
The mitochondrial inner membrane potential (MIMP) and Cytoplasmic ROS were assessed using tetramethyl rhodamine ester (TMRE, Invitrogen) and 2′,7′-dichlorodihydrofluorescein diacetate (H 2 DCF-DA, Invitrogen) respectively.
After addition of the fluorophores (30 µM H 2 DCF-DA, 100 nM TMRE) and incubation at 37°C for 30 min in the dark, cells were collected in DMEM and analyzed immediately with a MACSQuant® (Miltenyi-Biotec) flow cytometer. Forward and side scatter were used to gate the viable population of cells and the mean fluorescence intensity was determined with FLOWJO (TreeStar). K2S or EpCAM (CD326, Miltenyi-Biotec) positivity in the 655-730 nm bandpass channel was used to distinguish between tumor and fibroblast cells in co-culture.
For cell sorting, 4 × 10 6 co-cultured cells were analyzed and sorted using a FASCAria II sorter in two populations (K2S positive and K2S negative) corresponding to H1299 cells or fibroblasts respectively. Monocultured cells mixed just before sorting were used as control. Cells were centrifuged after cell sorting and the pellets were immediately frozen until RNA extraction. For the effect of TGF-β on MIMP and ROS levels, 0.75 × 10 6 cells were grown on MW6 plates and TGF-β was added to a final concentration of 10 ng/µL and refreshed every day. After 4 days, cells were harvested and MIMP and ROS were evaluated as described previously.
Immunofluorescence analysis
After 4 days of co-culture, immunofluorescences using specific antibodies for MCT4 (sc-50329, Santa Cruz Biotechnology), TOM20 (sc-17764, Santa Cruz Biotechnology) and α-SMA (1 A4; Abcam) were carried out as described previously [24] .
Statistics
Results were analyzed using a 2-tailed Student's t-test to assess statistical significance. Differences in PGC-1α and GAPDH/MT-CO1 ratio levels between Low and High fibrosis groups were evaluated using ANOVA. Bivariate correlations studies between gene expressions were analyzed using the Pearson correlation test. Values of P < 0.05 were considered statistically significant.
Results and discussion
The fibroblast component increases the glycolytic phenotype of tumors
As a first approach to study the role of the fibroblast component of tumors, we studied the correlation of PGC-1α (master regulator of mitochondrial metabolism) and the GAPDH/MT-CO1 ratio mRNA levels with the fibrosis grade in a cohort of 12 stage IIIA lung adenocarcinoma patients (Fig. 1A) . The results showed significant differences in PGC-1α (p=0.048) and GAPDH/MT-CO1 levels (p=0.006) between high and low fibrosis grade in the tumor biopsies. Interestingly, an increase in fibroblast component present in the tumor leads to higher levels of the ratio GAPDH/MT-CO1 and lower levels of PGC-1α, which are typical of an increased glycolytic metabolism and increased PET uptake [25] .
To confirm these results, expression data from 73 patients with stage IIIA pulmonary adenocarcinoma present in the TCGA database were analyzed using the bioinformatic tool "R2: Genomics Analysis and Visualization Platform". The correlations between vimentin levels (as marker of the fibroblast component) with the levels of genes related to glucose metabolism (Glycolysis, TCA and OXPHOS system) were analyzed. The results show a similar change to that described in our cohort of patients (Fig. 1B and Supplementary Table 1) . Overall, the results show a positive correlation of vimentin levels with genes related to an increase in glycolytic metabolism (GLUT3, HIF1A, HK3, ENO, PFKFB4…). On the other hand, genes related to the Krebs cycle (FH, MPC2, IDH3A, CS, SUCLG1…) or related to OXPHOS complexes (ATP5G3, NUDFA8,9,10, SDHA,C, COX5A…) and their assembly factors (COA5, COA6, NDUFAF5, UQCC2…) negatively correlate with vimentin levels in the tumor. Interestingly, some of these genes have been described in CAFs reprograming. The downregulation of IDH3A (Isocitrate dehydrogenase 3α) has been pointed out as responsible for the metabolic switch in CAFs trough HIF1α stabilization [26] . Remarkably, the only OXPHOS subunits that correlate positively with the vimentin levels are NDUFA4L2, COX7A1 y COX7B2, being the first two subunits related to hypoxia [27] [28] [29] and the third of unknown function.
It seems clear that an increase in fibroblast component in the tumor produces an increase in glycolytic genes with a decrease in OXPHOS genes. However, in literature, the glucose metabolism of differentiated cells such as normal fibroblasts is more oxidative than the metabolism of proliferative tumor cells [2] .
Our results evaluating the metabolism of monocultured tumor cells (A549 and H1299) and normal fibroblasts confirm this. The mitochondrial inner membrane potential (MIMP) and the galactose to glucose growth ratio were higher for the fibroblast cell lines compared to the tumor cell lines A549 and H1299 (Fig. 1C) .
Thus, despite the behavior of the cells in monoculture, the results on the tumor biopsies showed another role for the fibroblasts. Both results would indicate a possible effect of metabolic reprogramming towards glycolytic metabolism in the CAFs of NSCLC, that would modify the PET images [30] . However, we cannot rule out whether this relationship is produced by a specific metabolic change of tumor cells that would be more glycolytic in response to the fibroblasts present in the microenvironment, if it is the presence of metabolically reprogramed fibroblasts in the sample with a more glycolytic metabolism, or even a combination of both theories.
The in vitro co-culture of fibroblasts and NSCLC cells induce a metabolic reprogramming in both cell types
To clarify these issues and to deepen the mechanisms of this metabolic relationship in NSCLC we decided to move on to an in vitro model of co-cultured tumor and fibroblasts cell lines (Fig. 2A) .
To identify the A549 cells in the co-culture analysis, we exploited their positivity for the epithelial membrane marker EpCAM, which efficiently discriminates these cells from the accompanying fibroblasts through antibody labeling. On the contrary, since the H1299 line has lost many of the epithelial markers it is not possible to distinguish it from the co-cultured fibroblasts. Thus, we transfected the H1299 cell line to stably express the far-red fluorescent protein Katushka2S [22] . This strategy allowed us to identify the different cell lines when cocultured with fibroblasts and measure other parameters, both by flow cytometry and confocal microscopy ( Fig. 2A) .
After 4 days of co-culture with CF1 (Control Fibroblast 1), the MIMP was measured. MIMP is one of the most representative parameters modified in the metabolic reprogramming of co-cultured cells [10] . Surprisingly, we only saw changes in MIMP for the H1299 cell line, but no changes were observed for A549 cells when co-cultured (Fig. 2B) . Furthermore, when CF1 was co-cultured with the H1299 cell line a decrease in the MIMP was observed, effect that does not occur when CF1 is co-cultured with the A549 cell line.
To test if this metabolic reprogramming on H1299 cells was fibroblast-specific, or if it was just produced by different cells that cohabit in the same space, we co-cultured the H1299 K2S cell line with A549 cells (Fig. 2C) . The results showed no significant differences in both cell lines when co-cultured together, reinforcing the specific role of the (caption on next page) [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] fibroblasts in this process. We measured the LDHA and PGC-1α mRNA levels after the coculture in both, H1299 and fibroblast cells (Fig. 2D) . The results showed an increase of LDHA expression in the co-cultured fibroblasts and an increase of PGC-1α in the co-cultured tumor cells supporting a metabolic shift towards glycolysis in the fibroblasts and a metabolic shift towards OXPHOS in the tumor cells.
The OXPHOS function modification has been associated with an increase in mitochondrial mass in co-cultured tumor cells and a decrease of it in the fibroblasts [10, 12] . Beyond the levels of PGC-1α, we used the amount of TOM20 protein to directly asses the mitochondrial mass by confocal microscopy independently of the MIMP. The quantification of this protein revealed a significant increase of the mitochondrial mass when the tumor cells are co-cultured with control fibroblasts, however no statistically significant differences were seen on co-cultured control fibroblasts (Fig. 2E) . This point out different mechanisms for the MIMP changes in each cell type. Thus, the MIMP rise in tumor cells may be associated to PGC-1α and mitochondrial mass increase. However, the decrease of MIMP in fibroblast occurs without any significant modification in PGC-1α or mitochondrial mass levels.
These results support the existence of a metabolic reprogramming in NSCLC cells and fibroblasts in vitro, although this is restricted to some cell lines. Furthermore, these results may indicate that this change towards a more glycolytic metabolism in the whole tumor in patients with increased amount of fibroblasts is caused by the increased glycolytic metabolism of CAFs. This would also reinforce why fibroblasts participate in a worse prognosis of the patient [31] , since they not only favor immunosuppression [32] , metastasis [33] or drug resistance [7] , but also would generate a tumor mass with a greater glucose uptake, which is usually associated with tumor's aggressiveness [34, 35] .
The fact that one tumor cell line induces this phenomenon and the other one does not on the same fibroblast cell line speaks of some determining characteristic of this process present in the tumor cell line. If these differences were also to be found in patients, it would be possible to identify different groups of patients based on their ability to induce this effect on the microenvironment, which would have implications for the diagnosis, staging or new drugs development.
Fibroblast metabolic reprogramming is not dependent on α-SMA expression
In literature, the metabolic coupling between fibroblasts and tumor cells is associated with the fibroblast activation process measured as α-SMA expression [36] . The role of α-SMA levels in NSCLC is controversial, with studies indicating that it is an unfavorable prognostic factor [37] and studies in which α-SMA did not showed any prognostic information [38] .
We characterized the ability to activate fibroblasts from the two NSCLC cell lines used in the co-culture experiments (A549 and H1299). Our results show that the A549 cell line and the H1299 cell line present different ability to activate fibroblasts when co-cultured, measured as the induction of α-SMA expression in the fibroblasts (Fig. 3A) . After 4 days of co-culture, A549 cells induce an increase in α-SMA expression (at both, mRNA and protein levels) in the two different fibroblast cell lines. On the other hand, H1299 cells are only capable of activate the CF1, and to a much lesser extent than A549 cells.
This differential ability of the tumor cells correlates with the expression of epithelial markers, such as EpCAM (Fig. 3B ) and E-Cadherin (data not shown), as described before [39] . The H1299 cells with more mesenchymal characteristics were less effective at activating α-SMA expression than A549 cells with more epithelial characteristics.
Interestingly, since A549 is the cell line that induces more α-SMA in the fibroblasts but it is not able to reproduce the metabolic change, these results question the assumption in which the reverse Warburg effect is associated with the fibroblast activation, suggesting that these phenomena are two different entities that do not necessarily occur together.
On the other hand, these in vitro results suggest that α-SMA level may not be a good marker for the metabolic reprogramming effect induced by fibroblasts in NSCLC tumors. To test this hypothesis, we reanalyzed the patient's data from our cohort (data not shown) and from TCGA. The results show no correlation between α-SMA expression and PGC-1α or GAPDH/MT-CO1 (Fig. 3C) .
Fibroblast basal OXPHOS function modifies tumor cells metabolic reprogramming
It seems clear that there is a metabolic change in both cell types, whereas the H1299 tumor cells increase its OXPHOS function, the fibroblasts reduce it when co-cultured. We asked ourselves if this process occurred in a similar way if we co-cultivated the tumor cell line H1299 with a fibroblast with an affected OXPHOS function.
Coincidentally, when we characterized the mitochondrial function of the fibroblasts present in the laboratory, we observed deep differences in their galactose to glucose growth rate ratios as well as in their MIMP for one fibroblast cell line (Affected Fibroblast, AF) (Fig. 4A) . This result would indicate that these fibroblasts present an OXPHOS defect of unknown origin. Interestingly, this OXPHOS defect is somehow compensated by an increased glycolytic function as evidenced by their increased LDHA mRNA levels. Moreover, in order to have an isogenic model with a decreased OXPHOS function, we treated the CF1 with EtBr (ethidium bromide) [40] . The treatment with EtBr greatly reduced the MIMP, and specifically stopped the growth of cells in galactose, without affecting their growth in glucose (Fig. 4A) .
We studied the levels of MCT4 (responsible for the lactate export from the cytoplasm to the microenvironment) for both, monoculture and co-culture conditions (Fig. 4B) . The basal MCT4 levels of CF1 were not detectable by immunofluorescence. On the contrary, the CF1 treated with EtBr or the Affected Fibroblast showed a notable MCT4 expression reinforcing their higher glycolytic activity. Remarkably, after the co-culture with tumor cells, an increase of MCT4 levels was induced on CF1, similarly to the LDHA increase observed (Fig. 2B ) and therefore supporting a glycolytic shift in the fibroblasts. On the other hand, the CF1 treated with EtBr or the AF maintain their already high MCT4 levels that did not significantly change. Similar results were obtained analyzing MCT4 mRNA levels. CF1 showed lower MCT4 mRNA levels than the AF. Furthermore, MCT4 mRNA levels were induced in CF1 after tumor co-culture but no differences were observed after tumor co-culture in Affected Fibroblast MCT4 mRNA levels.
Additionally, after 4 days of co-culture with the different fibroblasts, the results showed a greater MIMP increase for the H1299 cell line when it is co-cultivated with fibroblasts with a diminished OXPHOS Fig. 2 (CF1) . TMRE in red, H1299 K2S positive cells in blue. Lower panel, representative flow cytometry analysis of the co-cultures. Fibroblast and tumor cells were not distinguishable by size and complexity (forward and side scatter). K2S (for H1299 cells) or EpCAM (for A549 cells) positivity was used to gate and discriminate the tumor cells from the fibroblasts (B) MIMP was evaluated as TMRE fluorescence determined by flow cytometry. Data are means relative to monocultured tumor cells. Note that there are significant differences in co-cultured cells for the H1299 but not for A549 cell line. (C) No significant differences in MIMP were seen in the co-culture between tumor cell lines. (D) The effect of fibroblast co-culture on LDHA and PGC-1α mRNA levels determinated by RT-qPCR (E) Mitochondrial mass was determinated by confocal quantification of TOM20 expression. Data are means from at least three different experiments and are represented relative to monocultured cells. Error bars indicate standard deviation. Student's t-test p-value was considered to be statistically significant when was < 0.05 (*=p ≤ 0.05). function (Fig. 4C) . On the other hand, the AF and the CF1 treated with EtBr do not behave the same way as the CF1 when co-cultured with H1299. Whereas the CF1 decrease its MIMP the AF or the CF1 treated with EtBr did not show any statistical differences (Fig. 4C) . It is possible that the latter cell lines are not able to diminish their OXPHOS function more than it is already reduced, which would also explain why they do not increase their expression of MCT4.
Moreover, we measured PGC-1α mRNA levels as indirect measurement of the mitochondrial biogenesis, which, as we had seen previously, was altered by the co-culture with CF1. Our results show a greater increase of the mitochondrial biogenesis when the H1299 line is co-cultivated with the AF. In turn, the decrease of PGC-1α expression is higher for these fibroblasts than for the CF1 when co-cultured with H1299 (Fig. 4D) . These results would indicate that this process occurs even on an OXPHOS-affected fibroblast. In fact, this seems to facilitate the MIMP and PGC-1α increase of the tumor cells. Fibroblasts with an affected OXPHOS function seems to facilitate the reverse Warburg effect probably through their higher supply of lactate due to their impaired OXPHOS function [41] . Recently, lactate has been proposed as a potential carbon source for lung tumors in vivo [42] and metabolic differences between CAFs from high and low glycolytic tumors have been found [34] .
All this data combined with the variability of mitochondrial function among healthy individuals (a common drawback in the study of mitochondrial diseases [43] ) would place the OXPHOS performance of fibroblasts as a modifier element of tumor metabolism.
In relation to the previous sections, these results confirm that the H1299 cell line presents the ability to modify the metabolic microenvironment in which is present, since it occurs in the presence of two fibroblasts from different origins. Furthermore, since the AF do not become significantly activated in the presence of the H1299 cell line (Fig. 3A) , but nevertheless they produce a greater effect on the MIMP of the tumor line, this result confirms that this process of metabolic reprogramming is independent of fibroblast activation measured as α-SMA induction.
Reactive oxygen species levels in co-cultured NSCLC cells
One of the main factors responsible for metabolism reprogramming is ROS [10] . We measured the basal ROS, in both tumor cell lines, using the fluorescent probe H 2 DCFH-DA. The results showed a significant fourfold increase of ROS for H1299 cells compared to A549 cells (Fig. 5A) .
When we analyzed the levels of ROS in the co-cultures, we observed a change of them for H1299 cells, but not for A549 cells, that maintain the same ROS levels (Fig. 5B-C) . Interestingly in H1299 co-culture, ROS levels increase in both cell types, suggesting some kind of reciprocal signal.
In addition, as well as for membrane potential, there is a differential effect of the co-culture with different fibroblast cells for ROS. The coculture with the AF produces a greater increase of ROS in the tumor cells than the co-culture with CF1. On the contrary, the increase of ROS in both fibroblasts was similar.
The differences in basal ROS levels between tumor cells might explain why this metabolic reprogramming is restricted to the H1299 cells, while A549 cells are not capable of producing this effect. Reinforcing our results, the role of ROS in this phenomenon has been pointed out previously as the starting mechanism for this process [10] .
On the other hand, it has been described how an increase of ROS in the cell media produces an increase of the fibroblast TGF-β levels [44] . Our results showed an increase of TGF-β mRNA levels for all the cell lines when co-cultured (Fig. 5D) . Again, the effect on the tumor cell line is greater when it is co-cultured with the AF. In turn TGF-β levels are key in the metabolic reprogramming towards an increase of fibroblast glycolysis and production of lactic acid, substrate for the tumor cells [26, 36] . When we incubate the cells with TGF-β we see a similar effect to that produced by the co-culture; tumor cells increase the MIMP while fibroblasts reduce it. On the other hand TGF-β induces an increase of ROS in the two cell lines similar to that induced by the co-culture (Fig. 5E ).
Conclusions
This study provides a better understanding of the actual tumor metabolism as it focuses on functional studies and takes into account that tumor cells are not isolated but are in constant communication to other cell types forming a particular microenvironment. Our results support the existence of the Reverse Warburg Effect in lung cancer. Interestingly, this process is restrained to some tumor cell lines; it is not necessarily associated to fibroblast activation; may be modified by different fibroblasts and implies an alteration of ROS and TGF-β levels.
Out of all the previously stated information, knowing the metabolic relationships between different cell types may provide: improvements in diagnosis through better interpretation of PET images; identification of different groups of patients according to their metabolic microenvironment that could have different prognoses; or even the discovery of key therapeutic targets for developing new drugs.
